Lifeloc Technologies AAQS 2024
Lifeloc Technologies AAQS
2
Ticker
LCTC
ISIN
US53220Y2072
Lifeloc Technologies omab hetkel AAQS väärtuseks 2. Kõrget AAQS-i võib pidada positiivseks märgiks, et ettevõte areneb edukalt. Investorid võivad eeldada, et ettevõte on heas seisus kasumi teenimiseks. Teisest küljest on oluline vaadelda Lifeloc Technologies aktsia AAQS-i võrdluses saadud kasumite ja sama sektori teiste ettevõtetega. Kõrge AAQS ei ole absoluutne garantii positiivseks tulevikuks. Ainult nii on võimalik saada täielik ülevaade ettevõtte sooritusest. Ettevõtte arengu paremaks hindamiseks on oluline võrrelda AAQS-i sama sektori teiste ettevõtetega. Üldiselt peaksid investorid alati vaatlema ettevõtte AAQS-i seoses teiste näitajatega nagu kasum, EBIT, rahavoog ja muud, et teha põhjendatud investeerimisotsus.
Lifeloc Technologies Aktienanalyse
Mis teeb Lifeloc Technologies?
Lifeloc Technologies Inc is a company that has been a leader in the development of alcohol and drug testing devices for over 30 years. The company was founded in 1983 and is headquartered in Wheat Ridge, Colorado. Lifeloc focuses on manufacturing reliable and accurate alcohol and drug testing devices for applications in criminal and labor law, transportation, and healthcare. Lifeloc's business model is tailored to the needs of its customers. The company offers both direct sales and sales through a global distribution network. Lifeloc focuses on producing and selling alcohol and drug testing devices for drug activity monitoring, drug testing compliance for employees, drug analysis for government personnel, and medical testing centers. Lifeloc develops and manufactures a wide range of products for alcohol and drug testing. The company offers both individual devices and complete testing systems that cover a variety of methods for alcohol and drug testing. Products include alcohol testing devices for personal use and professional applications, drug testing devices for urine, saliva, and hair, and laboratory equipment for chemical analysis of drug substances. Lifeloc's various divisions cover applications in criminal and labor law, transportation, and healthcare. The company offers alcohol and drug testing devices for drug testing compliance to ensure that employees and service providers are tested for drugs and alcohol to ensure workplace safety. The company also offers products for correctional facilities to help offenders remember to stay sober. For the transportation sector, Lifeloc provides alcohol and drug testing devices for use in airplanes, ships, trucks, and other vehicles to ensure the safety of passengers and other road users. Lifeloc also offers products for use in healthcare, such as devices and test kits for drug testing analysis in hospitals and other medical facilities. Throughout its history, Lifeloc has overcome many challenges. A major milestone was the introduction of the Breathalyzer™ alcohol testing device in 1988, which is now considered an industry standard and used by government and law enforcement agencies worldwide. Another milestone was the introduction of Fingerscript™ technology in 2005, which allows for rapid on-site drug testing and is now used by many government agencies, law enforcement agencies, and companies. In conclusion, Lifeloc Technologies Inc plays a leading role as a pioneering company in the field of alcohol and drug testing worldwide. The company's business model is tailored to the needs of its customers, and it has developed a wide range of products that cover a variety of applications in criminal and labor law, transportation, and healthcare. Lifeloc has overcome many challenges over the years and is now a well-known company in the field of alcohol and drug testing worldwide. Lifeloc Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.Sagedased küsimused Lifeloc Technologies aktsia kohta
Aktsiasäästuplaanid pakuvad investoritele atraktiivset võimalust pikema aja jooksul vara koguda. Üheks peamiseks eeliseks on nn keskmise maksumuse efekt: investeerides regulaarselt kindla summa aktsiatesse või aktsiafondidesse, ostetakse automaatselt rohkem osakuid siis, kui hinnad on madalad, ja vähem, kui need on kõrged. See võib aja jooksul viia soodsama keskmise hinna per osakuni. Lisaks võimaldavad aktsiasäästuplaanid ka väikeinvestoritel pääseda ligi kallimatele aktsiatele, kuna nendega saab liituda juba väikeste summadega. Regulaarne investeerimine soodustab ka distsiplineeritud investeerimisstrateegiat ja aitab vältida emotsionaalsete otsuste, nagu impulsiivne ostmine või müümine. Peale selle saavad investorid osa aktsiate võimalikust väärtuse kasvust ning dividendide väljamaksetest, mida saab reinvesteerida, mis tugevdab intressiintressi efekti ning seeläbi investeeritud kapitali kasvu.
Andere Kennzahlen von Lifeloc Technologies
Meie Lifeloc Technologies Käive-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Lifeloc Technologies Käive. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse:
- Lifeloc Technologies Käive
- Lifeloc Technologies Kasum
- Lifeloc Technologies Kasumi ja hinna suhe
- Lifeloc Technologies KUV
- Lifeloc Technologies EBIT
- Lifeloc Technologies Dividend
- Lifeloc Technologies Aktsiad
- Lifeloc Technologies Turukapitalisatsioon
- Lifeloc Technologies Võlakoormus
- Lifeloc Technologies Kohustused
- Lifeloc Technologies Omakapital
- Lifeloc Technologies AAQS
- Lifeloc Technologies Töötajad
- Lifeloc Technologies ROE
- Lifeloc Technologies ROA
- Lifeloc Technologies ROCE